Differential diagnosis of central lymphoma and high-grade glioma: dynamic contrast-enhanced histogram

被引:16
作者
Zhang, Han-wen [1 ]
Lyu, Gui-wen [1 ]
He, Wen-jie [1 ]
Lei, Yi [1 ]
Lin, Fan [1 ]
Feng, Yu-ning [1 ]
Wang, Meng-zhu [2 ]
机构
[1] Shenzhen Univ, Affiliated Hosp 1, Hlth Sci Ctr, Dept Radiol,Shenzhen Second Peoples Hosp, 3002 SunGangXi Rd, Shenzhen 518035, Peoples R China
[2] Siemens Healthineers, Dept MR Sci Mkt, Guangzhou, Guangdong, Peoples R China
关键词
Dynamic contrast enhancement; high-grade glioma; central nervous system lymphoma; histogram; differential diagnosis; CENTRAL-NERVOUS-SYSTEM; GLIOBLASTOMA; DIFFUSION; CLASSIFICATION; GUIDELINES; UTILITY; MRI;
D O I
10.1177/0284185119896519
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background In clinical diagnosis, some central nervous system lymphomas (CNSL) are difficult to distinguish from high-grade gliomas (HGG). Purpose To evaluate the diagnostic efficacy of the histogram analysis of dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) in the identification of CNSL and HGG. Material and Methods In all, 43 patients diagnosed with HGG (n = 28) and CNSL (n = 15) by histopathology underwent DCE-MRI scanning. Differences in histogram parameters based on DCE-MRI between HGG and CNSL were analyzed by Mann-Whitney U test. In addition, receiver operating characteristic (ROC) analysis was performed. Short-term follow-up of patients was performed using Kaplan-Meier analysis to explore the survival rates of HGG and CNSL. Results For the ROC curve analysis, we demonstrate that the 10th percentile of K-trans (area under the curve [AUC] = 0.912, sensitivity = 86.7%, specificity = 92.9%), K-ep (AUC = 0.940, sensitivity = 93.3%, specificity = 79.6%), V-e (AUC = 0.907, sensitivity = 86.7%, specificity = 89.3%), and AUC (AUC = 0.904, sensitivity = 86.7%, specificity = 92.9%) were significantly different between the CNSL and HGG groups (P < 0.001), with high diagnostic efficiency. Table 2 shows that the histogram features based on AUC maps (10th, 25th, median, 75th, 90th, and mean) were always significantly higher in the CNSL group than in the HGG group (P < 0.001). There was no significant difference in V-p or in the 75th, 90th and mean of K-trans, K-ep, and Ve between the CNSL and HGG groups (P > 0.05). Conclusion A histogram analysis of DCE-MRI identified significant differences between HGG and CNSL, and this will help in the clinical differential diagnosis of these conditions.
引用
收藏
页码:1221 / 1227
页数:7
相关论文
共 27 条
  • [1] Clinical Significance of Discrepancy between Arterial Spin Labeling Images and Contrast-enhanced Images in the Diagnosis of Brain Tumors
    Abe, Takashi
    Mizobuchi, Yoshifumi
    Sako, Wataru
    Irahara, Saho
    Otomi, Yoichi
    Obama, Yuki
    Nakajima, Kohei
    Khashbat, Delgerdalai
    Majigsuren, Mungunkhuyag
    Kageji, Teruyoshi
    Nagahiro, Shinji
    Harada, Masafumi
    [J]. MAGNETIC RESONANCE IN MEDICAL SCIENCES, 2015, 14 (04) : 313 - 319
  • [2] Differentiating between Glioblastoma and Primary CNS Lymphoma Using Combined Whole-tumor Histogram Analysis of the Normalized Cerebral Blood Volume and the Apparent Diffusion Coefficient
    Bao, Shixing
    Watanabe, Yoshiyuki
    Takahashi, Hiroto
    Tanaka, Hisashi
    Arisawa, Atsuko
    Matsuo, Chisato
    Wu, Rongli
    Fujimoto, Yasunori
    Tomiyama, Noriyuki
    [J]. MAGNETIC RESONANCE IN MEDICAL SCIENCES, 2019, 18 (01) : 53 - 61
  • [3] New MR perfusion features in primary central nervous system lymphomas: pattern and prognostic impact
    Blasel, Stella
    Vorwerk, Rieke
    Kiyose, Makoto
    Mittelbronn, Michel
    Brunnberg, Uta
    Ackermann, Hanns
    Voss, Martin
    Harter, Patrick N.
    Hattingen, Elke
    [J]. JOURNAL OF NEUROLOGY, 2018, 265 (03) : 647 - 658
  • [4] Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patients
    Blumenthal, Deborah T.
    Dvir, Addie
    Lossos, Alexander
    Tzuk-Shina, Tzahala
    Lior, Tzach
    Limon, Dror
    Yust-Katz, Shlomit
    Lokiec, Alejandro
    Ram, Zvi
    Ross, Jeffrey S.
    Ali, Siraj M.
    Yair, Roi
    Soussan-Gutman, Lior
    Bokstein, Felix
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2016, 130 (01) : 211 - 219
  • [5] Diagnostic delay and prognosis in primary central nervous system lymphoma compared with glioblastoma multiforme
    Cerqua, R.
    Balestrini, S.
    Perozzi, C.
    Cameriere, V.
    Renzi, S.
    Lagalla, G.
    Mancini, G.
    Montanari, M.
    Leoni, P.
    Scerrati, M.
    Iacoangeli, M.
    Silvestrini, M.
    Luzzi, S.
    Provinciali, L.
    [J]. NEUROLOGICAL SCIENCES, 2016, 37 (01) : 23 - 29
  • [6] Clinical value of magnetic resonance imaging in identifying multiple cerebral gliomas from primary central nervous system lymphoma
    Chen, Yushan
    Zhan, Alai
    [J]. ONCOLOGY LETTERS, 2019, 18 (01) : 593 - 598
  • [7] Primary central nervous system lymphoma and atypical glioblastoma: differentiation using the initial area under the curve derived from dynamic contrast-enhanced MR and the apparent diffusion coefficient
    Choi, Yoon Seong
    Lee, Ho-Joon
    Ahn, Sung Soo
    Chang, Jong Hee
    Kang, Seok-Gu
    Kim, Eui Hyun
    Kim, Se Hoon
    Lee, Seung-Koo
    [J]. EUROPEAN RADIOLOGY, 2017, 27 (04) : 1344 - 1351
  • [8] Primary Central Nervous System Lymphoma
    Dong, Yan-Hong
    Teng, Zhen-Jie
    Hu, Ming
    Wei, Ci
    Chen, Ying-Min
    Zhao, Huan-Fen
    Zhang, Shu-Qian
    Lyu, Pei-Yuan
    [J]. CHINESE MEDICAL JOURNAL, 2016, 129 (05) : 609 - 611
  • [9] Pretreatment dynamic contrast-enhanced MRI biomarkers correlate with progression-free survival in primary central nervous system lymphoma
    Hatzoglou, Vaios
    Oh, Jung Hun
    Buck, Olivia
    Lin, Xuling
    Lee, Michelle
    Shukla-Dave, Amita
    Young, Robert J.
    Peck, Kyung K.
    Vachha, Behroze
    Holodny, Andrei I.
    Grommes, Christian
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2018, 140 (02) : 351 - 358
  • [10] Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology
    Hoang-Xuan, Khe
    Bessell, Eric
    Bromberg, Jacoline
    Hottinger, Andreas F.
    Preusser, Matthias
    Ruda, Roberta
    Schlegel, Talli
    Soussain, Carole
    Abacioglu, Ufuk
    Cassoux, Nathalie
    Deckert, Martina
    Dirven, Siemens M. F.
    Ferreri, Andres J. M.
    Graus, Francesc
    Henriksson, Roger
    Herdinger, Ulric
    Taphoorn, Martin
    Soffietti, Riccardo
    Weller, Michael
    [J]. LANCET ONCOLOGY, 2015, 16 (07) : E322 - E332